Opens in a new tab

RGCC Testing

RGCC testing uses advanced technology to analyze circulating tumor cells (CTCs), enabling personalized cancer detection and treatment strategies.

Request Appointment
female scientist holding test tube in a lab

Revolutionizing Cancer Detection and Treatment: The Role of RGCC Lab Testing

The complexity of cancer demands innovative approaches in both detection and treatment, and RGCC lab testing stands at the forefront of this revolution. By utilizing advanced technology to analyze circulating tumor cells (CTCs), RGCC testing not only transforms cancer detection but also paves the way for personalized and effective treatment strategies.

Unveiling the Potential of RGCC Lab Testing

RGCC, or Research Genetic Cancer Centre, specializes in analyzing CTCs, the cells responsible for spreading cancer throughout the body. This testing provides critical insights into the genetic mutations and unique profiles of these cells, enabling the anticipation of cancer behavior and the customization of treatment plans. Beyond detection, RGCC offers tests that assess drug efficacy, immune function, and the therapeutic value of natural cancer agents, while also detecting metastatic tumors.

Elevating Cancer Treatment Through RGCC Innovations

RGCC testing enhances cancer care by enabling early detection and personalized treatment. Identifying CTCs at initial stages provides crucial information for crafting strategies tailored to the individual’s cancer profile, ensuring precision in treatment.

Innovative RGCC Treatments Shaping the Future of Cancer Care

RGCC supports the development of cutting-edge treatments, including:

  • Dendritic Cell Therapy: This immunotherapy strengthens the immune system’s ability to combat cancer by leveraging dendritic cells to recognize and attack cancer cell antigens, reducing systemic side effects.
  • Vaccine Prep (ATA): This therapy activates specific immune cells using fragments from dying tumor cells, promoting the maturation of dendritic cells to enhance the immune response against cancer.
  • Clavic-Q-RE: As an adoptive cell therapy, Clavic-Q-RE stimulates a robust immune response using various cell types from the patient’s own sample, targeting tumor antigens effectively.
  • Q-REstrain: This therapy employs microRNAs to regulate gene expression, targeting and degrading specific mRNA to manage overexpressed genes in cancer treatment.

In conclusion, RGCC lab testing marks a significant advancement in cancer detection and treatment, providing pathways to early detection, personalized medicine, and innovative therapies. At the Center for Wellness, our providers embrace an advanced approach to cancer treatments, focusing on personalized care. When you’re ready to explore these transformative options, we invite you to make an appointment. Reach out today and let us guide you on your journey to wellness.